You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CDK2/4/6

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hormone Receptor-positive Advanced Breast Cancer Trial (chidamide,fulvestrant)

Not yet recruiting
  • Hormone Receptor-positive Advanced Breast Cancer
  • (no location specified)
Apr 12, 2023

ER-positive Breast Cancer, HER2-negative Breast Cancer, Metastatic Cancer Trial in Madison, Milwaukee (Onapristone, Fulvestrant)

Recruiting
  • ER-positive Breast Cancer
  • +2 more
  • Madison, Wisconsin
  • +1 more
Jul 7, 2022

Meningioma Trial in Phoenix (Abemaciclib, Placebo)

Not yet recruiting
  • Meningioma
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Jul 4, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

Solid Tumors Trial (ARTS-021, CDK 4/6 inhibitor, Fulvestrant 50 MG/ML Prefilled Syringe)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
May 17, 2023

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Esophagus Squamous Cell Carcinoma Trial in Beijing (Palbociclib, Afatinib)

Recruiting
  • Esophagus Squamous Cell Carcinoma
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
May 17, 2023

Solid Tumor Trial (Dalpiciclib)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Aug 22, 2022

Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets, SPH4336 Tablets Placebo)

Not yet recruiting
  • Locally Advanced or Metastatic Breast Cancer
  • SPH4336 Tablets
  • SPH4336 Tablets Placebo
  • Guangzhou, Guangdong, China
    Affiliated Cancer Hospital, Sun Yat-sen University
May 8, 2023

Advanced or Metastatic Breast Cancer Trial (PF-07220060, Fulvestrant, Everolimus)

Not yet recruiting
  • Advanced or Metastatic Breast Cancer
  • (no location specified)
Oct 24, 2023

GBM, Glioblastoma, Brain Tumor Trial in Dallas (Abemaciclib, Bevacizumab)

Active, not recruiting
  • GBM
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 23, 2022

Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast Cancer

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center
Jan 17, 2022

Healthcare Resource Utilization and Costs of Metastatic

Completed
  • Metastatic Breast Cancer
  • East Hanover, New Jersey
    Novartis Investigative Site
Dec 15, 2021

Breast Cancer Trial in Singapore (Lenvatinib + Letrozole, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • Singapore, Singapore
    Nationa University Hospital
Jan 4, 2022

Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial

Not yet recruiting
  • Malignant Female Reproductive System Neoplasm
  • +3 more
  • Biopsy
  • +7 more
  • (no location specified)
Nov 9, 2023

Personalised Disease Monitoring in Metastatic Breast Cancer

Recruiting
  • Breast Cancer Metastatic
  • Estrogen Receptor-positive Breast Cancer
    • Gothenburg, Sweden
    • +6 more
    Dec 7, 2022

    Advanced HR+ HER2 Negative Breast Carcinoma Trial in Tianjin (Enituzumab injection+Abesili tablets+Anastrozole tablets)

    Recruiting
    • Advanced HR+ HER2 Negative Breast Carcinoma
    • Enituzumab injection+Abesili tablets+Anastrozole tablets
    • Tianjin, China
      Tianjin Cancer Hospital
    Apr 6, 2022

    HR+/HER2-negative Breast Cancer, Metastatic Breast Cancer Trial (Evexomostat)

    Not yet recruiting
    • HR+/HER2-negative Breast Cancer
    • Metastatic Breast Cancer
    • (no location specified)
    Jul 7, 2022

    Breast Cancer Trial in Australia, Canada, New Zealand (Ipatasertib, Fulvestrant, Placebo)

    Recruiting
    • Breast Cancer
    • Bowral, New South Wales, Australia
    • +37 more
    Aug 8, 2022

    Breast Cancer Trial (Gedatolisib, Palbociclib, Fulvestrant)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Aug 12, 2022

    Metastatic Breast Cancer Trial in Zhengzhou (Pyrotinib, SHR6390)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Mar 7, 2022

    Head Neck Cancer Trial in Birmingham (Cohort 1 Not Previously Treated, Cohort 2 Treated Previously)

    Terminated
    Has Results
    • Head and Neck Cancer
    • Cohort 1 Not Previously Treated
    • Cohort 2 Treated Previously
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jun 16, 2021

    HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World

    Terminated
    Has Results
    • Breast Cancer
      • New York, New York
        Pfizer United States
      Jan 14, 2022

      Breast Cancer Stage IV Trial in Nice, Villejuif (Alpelisib, Ribociclib)

      Not yet recruiting
      • Breast Cancer Stage IV
      • Nice, France
      • +1 more
      Nov 14, 2022

      Triple-negative Breast Cancer Trial in Shanghai (Pyrotinib with Capecitabine, AR inhibitor combined with everolimus(B1) or

      Recruiting
      • Triple-negative Breast Cancer
      • Pyrotinib with Capecitabine
      • +6 more
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 8, 2022